News Sentiment

CHE sentiment intelligence

Chemed Corp news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 56 Balanced news tone 54 relevant articles
Exchange NYSE United States
Sector Healthcare Market context
Industry Medical Care Facilities Read-through group
Latest close 488.59 Week of 10 Jul 2026
Weighted tone 56/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

81/100 classification confidence.

Company focus 54

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend active

-0.2% over one week, +16.5% over four weeks, trend active, and near fair-value range.

Latest direct headline Neutral

Chemed Corporation $CHE Shares Sold by Schwartz Investment Counsel Inc.

Market Reaction

Balanced read

56/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 81/100 classification
One-week reaction -0.2% Price digesting
Trend fit Trend active 16.5% over four weeks
Fair value -5.7% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 19
Neutral 32
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 54
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 12
MarketBeat 8
TradingView 7
simplywall.st 5
AD HOC NEWS 3
Investing.com 2
GuruFocus 2
Stock Titan 2

Event Lens

What the news is about

Classified themes
Market update 32
Earnings 16
Analyst action 3
Capital return 1
Deals and strategy 1
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 54
Investing.com Direct company coverage

Chemed Corp stock hits 52-week high at 492.42 USD

Chemed Corp (CHE) stock recently hit a 52-week high of $492.42, reflecting strong investor confidence and significant year-to-date gains. InvestingPro analysis suggests the stock is undervalued, and the company has consistently raised its dividend for 17 consecutive years. This a

Tone
Neutral 50/100
Event
Capital return
Published
11 Jul 2026 01:41
Source
Investing.com
MarketBeat Direct company coverage

Chemed (NYSE:CHE) Price Target Raised to $510.00 at Bank of America

Bank of America has increased its price target for Chemed (NYSE:CHE) to $510.00 from $450.00, maintaining a "neutral" rating, which suggests a potential upside of 6.38%. This adjustment follows the company's recent earnings report where it surpassed EPS estimates but slightly mis

Tone
Positive 64/100
Event
Analyst action
Published
09 Jul 2026 12:40
Source
MarketBeat
TradingView Direct company coverage

ETFs Investing in Chemed Corporation Stocks

This article provides a list of Exchange Traded Funds (ETFs) that hold stocks of Chemed Corporation (CHE). The ETFs are sorted by their market value and include details such as weight in the fund, issuer, management style, focus, expense ratio, assets under management (AUM), pric

Tone
Neutral 50/100
Event
Market update
Published
09 Jul 2026 00:45
Source
TradingView
MarketBeat Direct company coverage

Chemed Corporation (NYSE:CHE) Receives Consensus Recommendation of "Hold" from Analysts

Chemed Corporation (NYSE:CHE) has received a consensus "Hold" recommendation from analysts, with an average 12-month price target of $501.50. Recent analyst actions have been mixed, including some downgrades to "Hold" or "Sector Perform" and some upgrades. The company reported be

Tone
Neutral 50/100
Event
Analyst action
Published
05 Jul 2026 10:09
Source
MarketBeat
GuruFocus Direct company coverage

AMG River Road Small Cap Value Fund's Chemed Corp(CHE) Holding History

The AMG River Road Small Cap Value Fund holds 43,295 shares of Chemed Corp (CHE), valued at $18.40 million as of April 30, 2026, representing 1.86% of its portfolio. The fund initiated its position in Q2 2026 with purchases at an average price of $411.42 per share. With CHE's cur

Tone
Positive 66/100
Event
Market update
Published
05 Jul 2026 01:11
Source
GuruFocus
Stock Traders Daily Direct company coverage

Discipline and Rules-Based Execution in CHE Response

This article provides an AI-generated analysis of Chemed Corp (NYSE: CHE), noting strong near and mid-term sentiment and compelling upside potential due to a lack of resistance levels above the current price. It outlines three distinct institutional trading strategies—Position, M

Tone
Positive 71/100
Event
Market update
Published
04 Jul 2026 21:34
Source
Stock Traders Daily
MSN Direct company coverage

Activist Barington targets healthcare firm Chemed

Barington Capital Group, an activist investor, has taken a stake in healthcare firm Chemed. The activist fund is known for pushing for corporate changes and improvements in shareholder value. Further details about Barington's specific demands or plans for Chemed were not immediat

Tone
Positive 69/100
Event
Deals and strategy
Published
04 Jul 2026 00:11
Source
MSN
Investing.com South Africa Direct company coverage

Chemed Corp stock hits 52-week high at $484.86 By Investing.com

Chemed Corp's stock recently hit a new 52-week high of $484.86, reflecting positive investor sentiment and steady growth, with shares trading just under its 52-week peak. The company has shown a 1.63% increase over the past year and more significant returns of 13.77% over six mon

Tone
Positive 81/100
Event
Market update
Published
03 Jul 2026 11:39
Source
Investing.com South Africa
MarketBeat Direct company coverage

Boston Trust Walden Corp Trims Position in Chemed Corporation $CHE

Boston Trust Walden Corp reduced its stake in Chemed Corporation (NYSE:CHE) by 7.3% in the first quarter, selling 16,044 shares and retaining 205,197 shares valued at $77.5 million. Chemed recently reported stronger-than-expected quarterly earnings with an EPS of $5.65, though re

Tone
Neutral 50/100
Event
Earnings
Published
03 Jul 2026 07:12
Source
MarketBeat
Investing.com Direct company coverage

Chemed Corp stock hits 52-week high at $484.86

Chemed Corp's stock recently reached a 52-week high of $484.86, trading just under its peak of $486.57. This growth reflects positive investor sentiment, with the stock increasing by 1.63% over the past year, 13.77% over six months, and 12.69% year-to-date. The company also surpa

Tone
Positive 82/100
Event
Market update
Published
03 Jul 2026 00:11
Source
Investing.com
AD HOC NEWS Direct company coverage

Chemed Corp highlights steady healthcare and services footprint. Investors focus on long-term earnin

Chemed Corp operates a unique dual business model, combining hospice and palliative care with residential and commercial services like plumbing and drain cleaning. This structure attracts investors seeking diversified, defensive cash flows by blending a healthcare segment driven

Tone
Positive 66/100
Event
Balance sheet
Published
02 Jul 2026 18:41
Source
AD HOC NEWS
Market source Direct company coverage

Chemed To Report Second Quarter 2026 Earnings July 28, Related Conference Call To Be Held On July 29

Chemed Corporation announced it will release its second-quarter 2026 financial results on Tuesday, July 28, 2026, after market close. A conference call and webcast will follow on Wednesday, July 29, 2026, at 10 a.m. ET, for investors to discuss the results and business updates. C

Tone
Neutral 50/100
Event
Earnings
Published
02 Jul 2026 12:41
Source
Market source
Stock Titan Direct company coverage

Chemed to post Q2 results July 28, then host webcast July 29

Chemed Corporation (NYSE: CHE) announced it will release its second-quarter 2026 financial results on Tuesday, July 28, 2026, after the NYSE market close. The company will then host a conference call and webcast on Wednesday, July 29, 2026, at 10 a.m. ET to discuss the results an

Tone
Neutral 50/100
Event
Earnings
Published
02 Jul 2026 01:11
Source
Stock Titan
GuruFocus Direct company coverage

Chemed Corp (CHE) Shares Surge 3.2% -- What GF Score of 86 Tells Investors

Chemed Corp (CHE) shares recently surged 3.2% to $480.87, yet the stock remains "Modestly Undervalued" according to GuruFocus' GF Value™ of $662.41. The company boasts a strong GF Score™ of 86/100, reflecting robust financial strength, profitability, growth, and valuation, despit

Tone
Positive 66/100
Event
Market update
Published
01 Jul 2026 23:40
Source
GuruFocus
MarketBeat Direct company coverage

Fort Washington Investment Advisors Inc. OH Has $23.52 Million Stake in Chemed Corporation $CHE

Fort Washington Investment Advisors Inc. OH increased its stake in Chemed Corporation by 20.3% in Q1, now holding 62,264 shares valued at $23.52 million. Chemed reported better-than-expected Q1 earnings of $5.65 per share, though revenue slightly missed estimates. The company rec

Tone
Positive 64/100
Event
Earnings
Published
29 Jun 2026 08:11
Source
MarketBeat
TradingView Direct company coverage

Price to earnings forward of Chemed Corp – NYSE:CHE

This article provides a brief overview of Chemed Corp (NYSE: CHE) financials, specifically focusing on its forward price-to-earnings ratio. It appears to be a stub or partial financial data page from TradingView. The content is sparse, highlighting general financial information w

Tone
Neutral 50/100
Event
Earnings
Published
25 Jun 2026 22:09
Source
TradingView
TradingView Direct company coverage

Price to sales forward of Chemed Corp – NYSE:CHE

This article provides financial information for Chemed Corp (NYSE:CHE), focusing on its forward price-to-sales ratio. It appears to be a stub or a section of a larger financial data platform, indicating the period, value, and change of this financial metric for the company.

Tone
Neutral 50/100
Event
Market update
Published
25 Jun 2026 20:09
Source
TradingView
TradingView Direct company coverage

Chemed Corporation Actuals & Estimates (NYSE:CHE)

This article provides a comprehensive overview of Chemed Corporation (NYSE: CHE) financials, stock performance, and analyst estimates. It covers historical price data, future price forecasts, earnings, revenue, dividends, and other key financial indicators to help investors make

Tone
Positive 60/100
Event
Earnings
Published
25 Jun 2026 19:41
Source
TradingView
TradingView Direct company coverage

Enterprise value to EBIT forward of Chemed Corp – NYSE:CHE

The article provides a snapshot of Chemed Corp's (NYSE: CHE) enterprise value to EBIT forward. It is presented in a data-centric view from TradingView, focusing on key financial metrics for investors and analysts. The content is sparse, indicating it's likely a data point within

Tone
Neutral 50/100
Event
Market update
Published
25 Jun 2026 14:40
Source
TradingView
TradingView Direct company coverage

Enterprise value to revenue forward of Chemed Corp – NYSE:CHE

This article provides financial data for Chemed Corp (NYSE: CHE), specifically its enterprise value to revenue forward. It appears to be a snapshot of financial metrics for the company, accessible through TradingView. The content itself is terse, presenting a specific financial r

Tone
Neutral 50/100
Event
Earnings
Published
25 Jun 2026 00:11
Source
TradingView
TradingView Direct company coverage

Enterprise value to EBITDA forward of Chemed Corp – NYSE:CHE

This article focuses on the enterprise value to EBITDA forward for Chemed Corp (NYSE: CHE). It indicates that the market is currently closed with no trades, and provides navigation to various financial data, news, and technical analysis tools for the stock on TradingView.

Tone
Neutral 50/100
Event
Market update
Published
24 Jun 2026 14:10
Source
TradingView
AD HOC NEWS Direct company coverage

VITAS Healthcare Hospice Services from Chemed Corp - quiet support for complex end-of-life care in the US

VITAS Healthcare, a subsidiary of Chemed Corp, is a leading provider of end-of-life care in 14 US states, offering interdisciplinary hospice services at home or in inpatient units. The company specializes in complex cases, providing extensive support including 24/7 on-call nurses

Tone
Positive 66/100
Event
Market update
Published
22 Jun 2026 22:39
Source
AD HOC NEWS